Recurrence

show that particular cancer DNA marker in blood of patients with urothelial cancer following surgery to remove their tumour has a higher likelihood of cancer relapse. These patients also benefit from subsequent atezolizumab…

The addition of olaparib (Lynparza) to standard treatment significantly improved disease-free survival in patients with early, high-risk HER2-negative breast…

Intranasal INP104, dihydroergotamine mesylate (DHE) delivered by a novel investigational device, was associated with high rates of efficacy for first-treated migraine and low rates…

To evaluate for benefit, patients were randomized to receive either nivolumab or a placebo every two weeks for one year. Patients and physicians were blinded to the treatment. Both safety and quality of life were evaluated. Dr.…

Patients with early-stage non-small cell lung cancer (NSCLC) lived significantly longer without disease recurrence if they received atezolizumab (Tecentriq) after surgery and…

While there have been reports of lower extremity deep vein thrombosis following COVID-19, this is the first study in which COVID-19 triggered a recurrence in the upper arm of an active 85-year-old man who had a prior diagnosis of upper…